Takumi Maruhashi

8PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMolecular targetsAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 11, 2022
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.

Daisuke Sugiura, Il-Mi Okazaki, Takeo K Maeda

|Nov 24, 2021
DCIR and its ligand asialo-biantennary N-glycan regulate DC function and osteoclastogenesis.

Tomonori Kaifu, Rikio Yabe, Takumi Maruhashi

|Aug 26, 2021
PD-1 preferentially inhibits the activation of low-affinity T cells.

Kenji Shimizu, Daisuke Sugiura, Il-Mi Okazaki

|Jan 05, 2021
TARM1 contributes to development of arthritis by activating dendritic cells through recognition of collagens.

Rikio Yabe, Soo-Hyun Chung, Masanori A Murayama

|Sep 15, 2020
LAG-3: from molecular functions to clinical applications.

Takumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki

|Nov 15, 2019
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.

Natsumi Maeda, Takumi Maruhashi, Daisuke Sugiura

Pageof 2